Ardelyx reported $-400K in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Abbott USD 2.36B 178M Dec/2025
Amgen USD 3.92B 2.35B Sep/2025
Ardelyx USD -400K 467K Dec/2025
aTyr Pharma USD -25.75M 6.22M Sep/2025
Corcept Therapeutics USD 15.24M 16.45M Sep/2025
Curis USD -13.99M 7.38M Jun/2025
Sanofi EUR -1.16B 6.23B Dec/2025
TG Therapeutics USD 45.09M 19.18M Dec/2025
United Therapeutics USD 444M 6M Dec/2025
Xoma USD 15.98M 24.58M Jun/2024